Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HySSAS: Hydroxychloroquine as a Steroid-Sparing Agent in Pulmonary Sarcoidosis
2008-001340-39Phase 3Active
- Sponsor
- University of Milano-Bicocca
- Start
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of hydroxychloroquine in pulmonary sarcoidosis (2 arms), sponsored by University of Milano-Bicocca. Primary endpoint: Bone Mineral Density change (lumbar spine L1–L4). Started Jun 2008; status: active.
02
Drugs
hydroxychloroquine
03
Conditions
pulmonary sarcoidosis
Beyond the preview
Go deeper on 2008-001340-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001340-39.